Filing Flows › Sotera Health (SHC) › Q1 2026
Sotera Health (SHC) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 5, 2026
Sotera Health (SHC) reported revenue of $280M for the first quarter 2026 (Q1 2026), +10% from a year earlier and -8% from the quarter before. Operating margin was 15.2%, net earnings $26.6M (9.5% of revenue).
Sotera Health, Q1 2026: revenue $280M (+10% year over year), operating margin 15.2%, net earnings $26.6M, operating cash flow $29.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $280M | -8% | +10% |
| Gross profit | $147M | -11% | +9% |
| Operating profit | $42.6M | -40% | — |
| Net earnings | $26.6M | -24% | — |
| Operating cash flow | $29.4M | -71% | -47% |
What changed
Revenue was $280.0M in Q1 2026, up 10% year over year and down 8% from the previous quarter. Sterigenics was the largest line at 66% of revenue. Sterigenics added $16.5M year over year (up 10%), 64% of the total change. Nelson Labs declined 1%.
Gross margin was 52.5%, down 0.7 points from Q1 2025. Operating profit was $42.6M, a 15.2% margin (up 21.0 points year over year). Operating expenses fell 30% while revenue rose 10%. Net earnings were $26.6M. The effective tax rate was 37.6%.
Operating cash flow was $29.4M (down 47% year over year), 111% of net earnings. Non-cash charges added back $30.8M of depreciation and amortization and $14.4M of share-based compensation. Working capital and other items used $42.4M. Capital expenditures of $46.2M exceeded it, leaving free cash flow of −$16.7M.
Questions
What was Sotera Health's revenue in the first quarter 2026?
Sotera Health (SHC) reported revenue of $280M for the first quarter 2026 (Q1 2026), +10% from a year earlier and -8% from the quarter before.
Was Sotera Health profitable in the first quarter 2026?
Operating profit was $42.6M (15.2% of revenue) and net earnings $26.6M.
Source: Sotera Health 10-Q on SEC EDGAR.